Recent 8-K filings for NTRA

• May 7, 2026, 7:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01 ◈ Earnings Releases

  Natera Q1 revenue $696.6M (+39% YoY); raises FY2026 guidance by $120M to $2.78B midpt

  Revenue $696.6M (+38.8% YoY); tests processed 1,013,600 (+18.5%), oncology tests up 54.4%.

• April 1, 2026, 7:59 PM ET leadership materiality 0.25 neutral item 5.02item 9.01

  Natera appoints Eric Rubin to Board, increasing size to 11

  Eric Rubin appointed as independent Class I director effective March 26, 2026; term expires at 2028 annual meeting.

• February 26, 2026, 6:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  Natera Q4 2025 revenue $665.5M (+39.8% YoY); guides FY26 revenue $2.62-2.70B

  Revenue $665.5M Q4 2025 vs $476.1M Q4 2024 (+39.8%); FY2025 revenue $2,306.1M (+35.9%).

• January 12, 2026, 6:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  Natera preliminary Q4 rev ~$660M (+39% YoY), FY rev ~$2.3B (+35%), above outlook

  Q4 total revenue ~$660M (+39% YoY); FY 2025 ~$2.3B (+35%), ~$40M above top end of prior outlook.

• December 5, 2025, 6:59 PM ET M&A materiality 0.80 positive item 3.02item 8.01item 9.01

  Natera acquires Foresight Diagnostics for $275M upfront plus $175M earnouts

  All-stock acquisition includes $275M upfront consideration plus up to $175M in revenue- and reimbursement-based milestone earnouts.

• November 6, 2025, 6:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  Natera Q3 revenue up 35% to $592M; raises FY2025 guidance by $160M midpoint

  Revenue $592.2M (+34.7% YoY); product rev +35.3%; gross margin 64.9% vs 61.8%.

• August 7, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Natera Q2 revenue up 32% to $546.6M; raises FY2025 revenue outlook by $80M

  Total revenue $546.6M (+32.2% YoY); product revenue $544.4M (+32.3%).

• June 18, 2025, 7:59 PM ET other material materiality 0.40 neutral item 5.02item 5.07item 9.01

  Natera stockholders approve 3.6M share equity plan increase and reelect three directors

  Directors Baynes, Marcus, and Williams-Brinkley reelected with 91.0M, 79.7M, and 109.0M votes for, respectively.

• May 8, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Natera Q1 revenue $501.8M (+36.5% YoY); positive cash flow $23.2M

  Total revenue $501.8M (+36.5% YoY); product revenue $500.0M (+37.1%).

• March 12, 2025, 7:59 PM ET leadership materiality 0.35 neutral item 5.02item 9.01 ◈ executive_change

  Natera appoints Monica Bertagnolli to Board of Directors

  Board increased from 10 to 11; Bertagnolli appointed as Class III director, term expiring at 2027 annual meeting.

• February 27, 2025, 6:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  Natera Q4 revenue $476M (+53% YoY); guides 2025 revenue $1.87-1.95B

  Q4 total revenue $476.1M (+53% YoY); product revenue $472.9M (+53.9%).

• January 13, 2025, 6:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  Natera FY2024 preliminary revenue ~$1.7B (+56% YoY), positive cash inflow $86.3M

  Q4 2024 revenue ~$472M (+52% YoY); FY2024 revenue ~$1.7B (+56% YoY), ~$53M above top end of guidance.

• December 6, 2024, 6:59 PM ET leadership materiality 0.60 neutral item 5.02

  Natera amends employment agreement for Executive Chairman Matthew Rabinowitz

  Rabinowitz's base salary set at 50% of CEO's base salary, with annual cash bonus up to 85% of base salary.

• November 12, 2024, 6:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  Natera Q3 revenue $439.8M (+64% YoY), beats guidance; raises FY2024 forecast

  Revenue $439.8M (+63.9% YoY); product revenue up 64.4%; gross margin 61.8% vs 45.1%.

• August 8, 2024, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  Natera Q2 revenue up 58% to $413.4M, loss narrows to $37.5M, guides higher

  Revenue $413.4M (+58.1% YoY); product revenue $411.4M (+59.3%); gross margin 58.8% vs 45.2%.

• July 22, 2024, 7:59 PM ET debt materiality 0.60 neutral item 8.01

  Natera to redeem all $287.5M of 2.25% Convertible Notes due 2027 on Oct 11

  Natera elects to redeem all $287.5M aggregate principal of its 2.25% Convertible Senior Notes due 2027.

• June 18, 2024, 7:59 PM ET other material materiality 0.45 neutral item 5.02item 5.07item 9.01

  Natera shareholders approve amended equity plan adding 6M shares; director Botha reelected narrowly

  Amended 2015 Equity Incentive Plan approved with 85.9M for, 21.5M against; adds 6M shares, extends term 10 years, removes evergreen feature.

• May 9, 2024, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01 ◈ Earnings Releases

  Natera Q1 revenue $367.7M (+52% YoY), net loss narrows to $0.56/share; achieves positive cash flow

  Revenue $367.7M (+52.1% YoY); product revenue up 53.4%; gross margin 56.7% vs 38.7%.

• February 28, 2024, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases

  Natera Q4 revenue up 43% to $311M; net loss narrows; guides 2024 rev $1.32-1.35B

  Q4 revenue $311.1M (+43.2% YoY); product revenue up 44.3% to $307.3M.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.80 · Most common event earnings

13 positive 0 negative 6 neutral

source · NTRA on sec.gov